Delayed Release 6MP or Calcitriol vs. Purinethol
C2/13/6MP:CAL-01
Phase 2 small_molecule completed
Quick answer
Delayed Release 6MP or Calcitriol vs. Purinethol for Crohn's Disease is a Phase 2 program (small_molecule) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TEVA PHARMACEUTICAL INDUSTRIES LTD
- Indication
- Crohn's Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed